Medgenics Inc (NYSE MKT LLC:MDGN)

Data as of 1:33pm ET
 -0.10 / -1.85%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Medgenics, Inc. is a medical technology and therapeutics company, which develops protein therapeutics medical therapies. It develops Biopump technology which is used for the treatment of a range of chronic diseases and its product pipeline includes Epodure, Infradure and Hemodure The Company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA.

Contact Information

Medgenics, Inc.
Building 700
Wayne Pennsylvania 19087
P:(610) 254-4201
Investor Relations:



Mutual fund holders5.45%
Other institutional5.07%
Individual stakeholders23.27%

Top Executives

Michael F. ColaPresident, Chief Executive Officer & Director
John Harold LeamanChief Financial Officer
Nir ShapirVice President-Research & Development
Garry Arthur NeilChief Scientific Officer
Phyllis K. BellinSecretary, Treasurer, CAO & VP-Administration

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.